Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare Biotechnology

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd > RVV Insider Buying or Clinical Trial Update ?

<< Previous

Bullboard Posts

Next >>

Comment by TheTerminator1on May 11, 2021 9:51am

72 Views

Post# 33172764

RE:RE:RE:RVV Insider Buying or Clinical Trial Update ?

We will get the info whwn the time is right

1ottrunner wrote:
How about an update on exactly how many participants have enrolled.

It worries me that MF is as guarded in regards to providing the facts he could tell us.
He doesn't know results ( OR will delay any negative results as long as possible ) but RVV does know the number of recruits. How about an monthly update so investors know the trial is on some sort of track. The trial is set to complete in 20 days! Which is BS, but an update would be nice.

Or put the money into shrooms so that investors might realize a return

1ottrunner wrote: I hope it's a trial update. Of course if MF were willing to buy 4 million units at market I would accept that also...

TheTerminator1 wrote: Which one will come first